FHTX NASDAQ
Foghorn Therapeutics Inc.
1W: -42.3%
1M: -60.9%
3M: -60.0%
YTD: -61.1%
1Y: -59.0%
3Y: -66.3%
5Y: -85.8%
$2.02
-0.90 (-30.82%)
Weekly Expected Move ±17.6%
$1
$2
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$37M
Revenue
+52.0% YoY
$-65M
Net Income
+14.3% YoY
$-85M
Free Cash Flow
+6.5% YoY
100.0%
Gross Margin
-54.8%
Op. Margin
-44.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE81.9%
ROA-30.1%
ROIC26.3%
Valuation
P/E-2.0
P/B-1.8
EV/EBITDA-3.5
Leverage
Debt/Equity-0.53
Current Ratio3.36
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z-3.97
Beneish M-0.96